About me
Dr. Jawidzik is a board-certified neurologist who is serving as acting director of the Division of Neurology 2 (DN2) at FDA. She joined the Agency in 2015 in DN2 as a clinical reviewer on the migraine/TBI/stroke team. In 2020, she moved from DN2 to DN1 and has served in various positions in DN1 including clinical reviewer, team leader, and deputy director. Dr. Jawidzik earned her A.B. in molecular biology from Princeton and her M.D. from Georgetown. She completed her internship, neurology residency, and clinical neurophysiology fellowship at Rush University in Chicago. Prior to joining FDA, Dr. Jawidzik was in academic practice at Rush where she primarily saw general neurology patients and patients with neuromuscular diseases.
